Marker Therapeutics, Inc (MRKR)

Trade MRKR now with
8/15/2019 4:02:35 PM Marker Therapeutics Appoints Nadia Agopyan As VP Of Regulatory Affairs
8/6/2019 4:40:13 PM Marker Therapeutics Appoints Steve Elms To Its Board Of Directors
5/9/2019 4:04:13 PM Marker Therapeutics Q1 Loss/share $0.12 Vs. Loss $0.30 Year Ago
3/29/2019 7:42:19 AM WBB Securities Ups Marker Therapeutics, Inc (MRKR) To Strong Buy From Buy With $12.50 Up From $5.50 Price Target
2/25/2019 7:08:02 AM Marker Therapeutics Announces Clinical Update At Transplantation & Cellular Therapy Meetings Of ASBMT And CIBMTR 2019
11/27/2018 7:18:58 AM Marker Therapeutics Names Anthony Kim Its New CFO